Diagnosis
Multiple myeloma (suspected), bilateral pneumonia.
Patient:
Male, 62 years old, Russia
Physician:
Prof. Dr. med. Peter Reimer, Head of the Department of Oncology and Hematology, Clinic Essen-Werden
Diagnostic Evaluation & Expert Opinion by Prof. Peter Reimer:
At present, there is a clinical suspicion of multiple myeloma presenting alongside monoclonal gammopathy. However, this diagnosis requires formal confirmation through an advanced diagnostic workup.
To verify the diagnosis and determine the precise stage of the condition, we recommend performing a bone marrow biopsy from the iliac crest along with a bone marrow aspiration. If the diagnostic results confirm the diagnosis and satisfy the established CRAB criteria (hypercalcemia, renal insufficiency, anemia, bone lesions), an individualized therapeutic protocol will be initiated immediately.
Under current European treatment guidelines for patients under 65 years of age in good general health, the standard approach involves:
- Induction Therapy (3 months): Targeted drug therapy designed to rapidly reduce the burden of tumor cells and prepare the body for subsequent treatment stages.
- Stem Cell Mobilization & Harvesting: Collecting the patient's own healthy stem cells following induction.
- High-Dose Chemotherapy & Autologous Stem Cell Transplantation (ASCT): Consolidating remission to achieve long-term disease control.
If autologous transplantation is not clinically suitable due to concomitant medical conditions (comorbidities), alternative targeted medical therapies are available that offer high efficacy while remaining gentle on the body.
The final decision regarding the most suitable treatment pathway will be carefully made together with the patient once all diagnostic results and full clinical evaluations are complete.
The provided materials are for informational purposes only and do not replace an in-person medical consultation. Any procedures or treatments must be prescribed by a licensed physician.
Need an expert consultation? Book an appointment today: +49 170 62 47 020